Case

Our company strictly designs in accordance with relevant national laws, regulations, and industry standards during project implementation, while combining advanced technological means to ensure the quality, efficiency, and safety of the project.

Home/Case/Preclinical study
Recommended news

Breakthrough in drug resistance mechanism

Triple negative breast cancer produces chemoresistance through lipid metabolism reprogramming, revealing a new mechanism of fat cells protecting tumor cells

Innovation of drug sensitivity model

The organ like model of pancreatic cancer accurately predicts the efficacy of targeted drugs, providing reliable basis for clinical individualized treatment

New strategies for inflammation intervention

Anti fibrotic drugs significantly delay the progression of chronic pancreatitis carcinogenesis, and the therapeutic potential is validated in a mouse model

Immune target discovery

Identification of specific new antigens in humanized models of liver cancer, providing key targets for the development of dual antibody drugs

Antibiotic resistant strain Kexing

Optimizing bismuth containing quadruple therapy significantly improves the eradication rate of clinically resistant strains of Helicobacter pylori

Progress in myocardial infarction repair

Stem cell myocardial injection promotes vascular regeneration, and large-scale animal experiments have shown solid functional improvement
Product
Cell Separation Drug development Cell culture Monoclonal antibody Recombinant protein
Quick Links
About Case News Contact
Contact us
  • Add：A02 and A03, 5th floor, Zhongyuan Building Business Center, Jiangmen City, Guangdong Province
  • Tel：0750-321990/3690220
  • Email：info@xike123.cn
Copyright © 2025 Biology official website All right reserved.
Technical support：Xike Network